 |
|||||||||||||||
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
|||||||||||||||
What's New
03.09.10
Follow the Comparative Effectiveness Research Dollar: Avalere Finds NIH Focused on Costly Conditions, Healthcare Costs
03.05.10
Avalere Issue Brief Shows Cost and Quality Burdens From Rehospitalizations
02.19.10
Avalere Analysis Finds Medicare Advantage Enrollees Face Higher Premiums in 2010
» View all articlesFollow the Comparative Effectiveness Research Dollar: Avalere Finds NIH Focused on Costly Conditions, Healthcare Costs
03.05.10
Avalere Issue Brief Shows Cost and Quality Burdens From Rehospitalizations
02.19.10
Avalere Analysis Finds Medicare Advantage Enrollees Face Higher Premiums in 2010
» Sign up for email alerts
» About our logo
Web-based Audio Conference /
Evidence-based Medicine in Action /
Analysis of Federal Activity in Comparative Effectiveness Research
March 11, 2010 / 12:00 - 1:30 EDT
What does the government’s $1.1 billion investment in comparative effectiveness research mean for providers, patients, payers, and industry?
» Learn MoreLearn about Avalere’s new, yearlong audio conference program.
Spotlight On /
Analytics /
A new Avalere issue brief on rehospitalizations points to financial waste resulting from misaligned incentives between Medicare and Medicaid.